 |
PDBsum entry 4hfp
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
4hfp
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Autoactivation of thrombin precursors.
|
 |
|
Authors
|
 |
N.Pozzi,
Z.Chen,
F.Zapata,
W.Niu,
S.Barranco-Medina,
L.A.Pelc,
E.Di cera.
|
 |
|
Ref.
|
 |
J Biol Chem, 2013,
288,
11601-11610.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
|
|
 |
 |
|
Abstract
|
 |
|
Trypsin-like proteases are synthesized as inactive zymogens and convert to the
mature form upon activation by specific enzymes, often assisted by cofactors.
Central to this paradigm is that the zymogen does not convert spontaneously to
the mature enzyme, which in turn does not feed back to activate its zymogen
form. In the blood, the zymogens prothrombin and prethrombin-2 require the
prothrombinase complex to be converted to the mature protease thrombin, which is
unable to activate prothrombin or prethrombin-2. Here, we show that replacement
of key residues within the activation domain causes these zymogens to
spontaneously convert to thrombin. The conversion is started by the zymogen
itself, which is capable of binding ligands at the active site, and is abrogated
by inactivation of the catalytic residue Ser-195. The product of autoactivation
is functionally and structurally equivalent to wild-type thrombin. Zymogen
autoactivation is explained by conformational selection, a basic property of the
trypsin fold uncovered by structural and rapid kinetics studies. Both the
zymogen and protease undergo a pre-existing equilibrium between active and
inactive forms. The equilibrium regulates catalytic activity in the protease and
has the potential to unleash activity in the zymogen to produce autoactivation.
A new strategy emerges for the facile production of enzymes through zymogen
autoactivation that is broadly applicable to trypsin-like proteases of
biotechnological and clinical interest.
|
 |
|
|
|
|
 |